Onasemnogene abeparvovec

Orphan Drug Cold Chain RequiredNot registered in India

Description

Onasemnogene abeparvovec is a gene therapy for spinal muscular atrophy type 1. It delivers a functional copy of the SMN1 gene using an AAV9 vector.

Indications & Therapeutic Use

SMA Type 1 (pediatric patients)

Linked Diseases:

Spinal Muscular Atrophy
G12.0D009134

Evidence: Phase 3 STR1VE trial

Access Programs

Named Patient ProgramNamed Patient Program

Framework: Country-specific regulatory approvals

Typical timeline: 21 days

Buy / Source Onasemnogene abeparvovec — GNH India

6 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.

Browse all Onasemnogene abeparvovec products on GNH India

Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.

Available Through

This drug is available for procurement through the following fulfilment partner.

Fulfilment Partner
Onasemnogene abeparvovec
Generic NameOnasemnogene abeparvovec
Brands1 brand available
Active IngredientOnasemnogene abeparvovec-xioi
Drug ClassSMA Type 1 (pediatric patients)
ManufacturerNovartis Gene Therapies
Dosage FormsIV infusion
Medical CodeRxNorm:2284718
Orphan StatusYes — Orphan Drug
Cold ChainRequired
Lead Time14 days
Reg. StatusNot registered in India
Authority Signals
Last Verified3/11/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations1 Validated Nodes